OverviewThis is a summary of the European public assessment report (EPAR) for Karvezide. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for CoAprovel. It explains how the Committee for Medicinal Products for Human...
OverviewElucirem is a ‘contrast agent’, a medicine used to improve the contrast of images obtained during magnetic resonance imaging (MRI) examinations. This helps...
OverviewVueway is a ‘contrast agent’, a medicine used to improve the contrast of images obtained during magnetic resonance imaging (MRI) examinations. This helps...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
EMA, in close collaboration with the European Commission, has established a standard procedure for manufacturers of certain high-risk medical devices to request scientific...
OverviewRemicade is an anti‑inflammatory medicine. It is usually used when other medicines or treatments have failed, in adults with the following diseases:rheumatoid arthritis...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
OverviewPonvory is a medicine for treating adults with relapsing active forms of multiple sclerosis. Multiple sclerosis is a disease of the brain and spinal...
OverviewThis is a summary of the European public assessment report (EPAR) for Enyglid. It explains how the Committee for Medicinal Products for Human...
OverviewWyost is a medicine used to prevent bone complications in adults with advanced cancer that has spread to the bone. These complications include...